Carbon Ion Radiotherapy Offers Good Prostate Cancer Outcomes
The 10-year rates of cancer-specific and overall survival were 95.2% and 79.8%.
The 10-year rates of cancer-specific and overall survival were 95.2% and 79.8%.
Researcher calculates that 43,200 such injuries occurred in the U.S. from 2002-2010.
Desmopressin appears to reduce nocturia and other LUTS while also significantly increasing testosterone levels in late-onset hypogonadism.
Study demonstrates that men experience steady weight loss and decrease in waist circumference.
Repeat injections of onabotulinumtoxinA (BTXA) appear to benefit patients with non-neurogenic overactive bladder.
Leakage/incontinence topped the list at 11%, according to a study.
Gleason 8 tumors have a substantially better prognosis after radical surgery than Gleason 9 and 10 tumors.
Patients missed fewer days of work after undergoing medical expulsive therapy than after having early endoscopic stone removal.
The test was ordered for only about 8% of patients at high risk for urinary stone recurrence.
Relying on PSA doubling time from just one year of active surveillance can result in as many as one in five prostate cancer patients being advised to undergo curative treatment that may be unnecessary.